三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
TGRX-326片在RP2D时的抗肿瘤活性。(A-C)先前接受克唑替尼治疗的患者、未接受ALKTKI
TGRX-326片在RP2D时的抗肿瘤活性。(A-C)先前接受克唑替尼治疗的患者、未接受ALKTKI
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:108KB
图片尺寸:2302*1173
同报告图片
/
4
55Sx5LqO5Zu+54mH5Lit5rKh5pyJ5o+Q5L6b5YW35L2T55qE5pWw5o2u77yM5Zug5q2k5peg5rOV55Sf5oiQ5pWw5o2u6KGo5qC844CC5L2G5piv77yM5oiR5Y+v5Lul5Li65oKo5o+Q5L6b5LiA5Liq56S65L6L6KGo5qC877yM5oKo5Y+v5Lul5qC55o2u5a6e6ZmF5oOF5Ya15aGr5YaZ5pWw5o2u44CCCgp8IOmhueebriB8IOaVsOaNrjEgfCDmlbDmja4yIHwg5pWw5o2uMyB8CnwgLS0tIHwgLS0tIHwgLS0tIHwgLS0tIHwKfCDmjIfmoIcxIHwgICB8ICAgfCAgIHwKfCDmjIfmoIcyIHwgICB8ICAgfCAgIHwKfCDmjIfmoIczIHwgICB8ICAgfCAgIHwKCui1hOaWmeadpea6kO+8muWhlOWQieeRnuWFrOS8l+WPt++8jOS4reazsOivgeWIuOeglOeptuaJgA==
所属报告:
先声药业-港股公司深度报告:神经+肿瘤+自免三栖产品矩阵升级+研发创佳绩-250223(31页).pdf
打包全文图表
相关数据
图28、奈克替尼与竞品在CD74融合ROS1阳
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
收藏
行业数据
2025-08-19
原图定位
查看详情
图27、奈克替尼与竞品全性对比
fCDmr5LmgKfnsbvlnosgICB8IOWuieWliOWFi+abv+WwvCB8IOWFi+WUkeabv+WwvCAgICAgICB8IOaBqeabsuabv+WwvCB8CnwtLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLXwKfCDop4bop4npmpznoo0gICB8IDI4LjElICAgICAgfCA0OC4wJe+8iOacquaKpemBk++8iXwg4oCUICAgICAgICB8Cnwg5ZGz6KeJ6Zqc56KNICAgfCAxMy4zJSAgICAgIHwgMTcuMyUgICAgICAgICAgfCA0My4zJSAgICB8Cnwg55yp5pmVICAgICAgIHwgMTAuOSUgICAgICB8IOKAlCAgICAgICAgICAgICAgfCAzNC44JSAgICB8CgrotYTmlpnmnaXmupDvvJrlm73lrrbljLvkv53lsYDvvIzlhbTkuJror4HliLjnu4/mtY7kuI7ph5Hono3noJTnqbbpmaLmlbTnkIY=
收藏
行业数据
2025-08-19
原图定位
查看详情
无论IGHV突变状态如何,泽布替尼+索托克拉(左图)相比伊布替尼+维奈克
fCDnoJTnqbblkI3np7AgfCBJR0hW56qB5Y+YIHwgSUdIVuacqueqgeWPmCB8IOS4reS9jeaXtumXtO+8iOaciO+8iSB8CnwtLS0tLS0tLS0tLXwtLS0tLS0tLS0tfC0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS18CnwgQ0VMRVNUSUFMIDEwMSB8IDcuMiAgICAgIHwgNy4xICAgICAgICB8ICAgICAgICAgICAgfAp8IEZMQUlS56CU56m2ICAgfCAxOC4wICAgICB8IDExLjkgICAgICAgfCAgICAgICAgICAgIHw=
收藏
行业数据
2025-08-07
原图定位
查看详情
安奈克替尼安全性(非头对头)
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
收藏
行业数据
2025-02-10
原图定位
查看详情
截至2024年11月,仅埃克替尼和奥希替尼在我国获批辅助治疗EGFR敏感突变NSCLC
5aW955qE77yM5Lul5LiL5piv5oKo5Zu+54mH5Lit55qE5pWw5o2u6KGo5qC85ZKM6LWE5paZ5p2l5rqQ77yaCgp8IOiNr+eJqSAgICAgfCDlhazlj7ggICAgICAgICB8IOS4reWbvei/m+W6piB8IOWFrOekuuaXtumXtCAgICAgICB8IOe+juWbvei/m+W6piB8IOWFrOekuuaXtumXtCAgICAgICB8CnwtLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS18Cnwg5aWl5biM5pu/5bC8IHwg6Zi/5pav5Yip5bq3ICAgICB8IOiOt+aJuSAgICAgfCAyMDIxLTA0LTA3ICAgICB8IC0gICAgICAgIHwgMjAyMC0xMi0xOCAgICAgfAp8IOWfg+WFi+abv+WwvCB8IOi0nei+vuiNr+S4miAgICAgfCDojrfmibkgICAgIHwgMjAyMS0wNi0wMSAgICAgfCAtICAgICAgICB8IC0gICAgICAgICAgICAgIHwKfCDpmL/nvo7mm7/lsLwgfCDosarmo67oja/kuJogICAgIHwgSUlJ5pyf5Li05bqKIHwgMjAyMS0wMi0yMSAgICAgfCAtICAgICAgICB8IC0gICAgICAgICAgICAgIHwKfCDkvI/nvo7mm7/lsLwgfCDoib7lipvmlq8gICAgICAgfCBJSUnmnJ/kuLTluoogfCAyMDIxLTAzLTA0ICAgICB8IC0gICAgICAgIHwgLSAgICAgICAgICAgICAgfAp8IOeRnuWOhOabv+WwvCB8IOWco+WSjOiNr+S4miAgICAgfCBJSUnmnJ/kuLTluoogfCAyMDIyLTEyLTA4ICAgICB8IC0gICAgICAgIHwgLSAgICAgICAgICAgICAgfAp8IOi0neemj+abv+WwvCB8IOi0nei+vuiNr+S4mi/nm4rmlrnnlJ/niakgfCBJSUnmnJ/kuLTluoogfCAyMDIzLTAyLTI3ICAgICB8IC0gICAgICAgIHwgLSAgICAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77yaSW5zaWdodOOAgeW8gOa6kOivgeWIuOeglOeptuaJgA==
收藏
行业数据
2025-01-16
原图定位
查看详情
2015-2020年埃克替尼销售额及增长率
fCDlubTku70gfCDplIDllK7pop3vvIjkur/lhYPvvIkgfCBZb1kgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS18LS0tLS0tfAp8IDIwMTUgfCAxMCAgICAgICAgICAgICB8ICAgICAgfAp8IDIwMTYgfCAxMSAgICAgICAgICAgICB8IDEzJSAgfAp8IDIwMTcgfCAxMCAgICAgICAgICAgICB8IC0xJSAgfAp8IDIwMTggfCAxMiAgICAgICAgICAgICB8IDE4JSAgfAp8IDIwMTkgfCAxNSAgICAgICAgICAgICB8IDI0JSAgfAp8IDIwMjAgfCAxOCAgICAgICAgICAgICB8IDIxJSAgfAoK6LWE5paZ5p2l5rqQ77ya6LSd6L6+6I2v5Lia5bm05oql77yM5Lic5pa56K+B5Yi456CU56m25omA
收藏
行业数据
2024-08-01
原图定位
查看详情
安奈克替尼和依奉阿克销售额测算(亿元)
fCDogrrnmYzvvIjkuK3lm73vvIkgICAgICAgICB8IDIwMjQgICAgfCAyMDI1ICAgIHwgMjAyNiAgICB8IDIwMjcgICAgfCAyMDI4ICAgIHwgMjAyOSAgICB8IDIwMzAgICAgfAp8LS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS18LS0tLS0tLS0tfC0tLS0tLS0tLXwtLS0tLS0tLS18LS0tLS0tLS0tfC0tLS0tLS0tLXwtLS0tLS0tLS18Cnwg5paw5Y+R5Lq65pWw77yI5Lq677yJICAgICAgIHwgMSwxMzIsNTM5IHwgMSwxNjksMzUwIHwgMSwyMDYsMTYwIHwgMSwyNDIsOTcwIHwgMSwyNzksNzgwIHwgMSwzMTYsNTkxIHwgMSwzNTMsNDAxIHwKfCDmlrDlj5HkurrmlbDvvIjkuIfkurrvvIkgICAgIHwgMTEzLjI1ICB8IDExNi45NCAgfCAxMjAuNjIgIHwgMTI0LjMwICB8IDEyNy45OCAgfCAxMzEuNjYgIHwgMTM1LjM0ICB8Cnwg6Z2e5bCP57uG6IOe6IK655mM77yI5LiH5Lq677yJIHwgOTYuMjcgICB8IDk5LjM5ICAgfCAxMDIuNTIgIHwgMTA1LjY1ICB8IDEwOC43OCAgfCAxMTEuOTEgIHwgMTE1LjA0ICB8CnwgQUxLKy9ST1Mr77yI5LiH5Lq677yJICAgIHwgNi4yNiAgICB8IDYuNDYgICAgfCA2LjY2ICAgIHwgNi44NyAgICB8IDcuMDcgICAgfCA3LjI3ICAgIHwgNy40OCAgICB8Cnwg5Lqn5ZOB5biC5Y2g546HKCUpICAgICAgICB8IDIlICAgICAgfCA1JSAgICAgIHwgOCUgICAgICB8IDEwJSAgICAgfCAxNSUgICAgIHwgMTIlICAgICB8IDEwJSAgICAgfAp8IOayu+eWl+W5tOi0ueeUqO+8iOS4h+WFg++8iSAgIHwgMTUuMDAgICB8IDE0LjI1ICAgfCAxMy41NCAgIHwgMTIuODYgICB8IDEyLjIyICAgfCAxMS42MSAgIHwgMTEuMDMgICB8Cnwg6ZSA5ZSu6aKd77yI5Lq/5YWD77yJICAgICAgIHwgMS44OCAgICB8IDQuNjAgICAgfCA3LjIyICAgIHwgOC44MyAgICB8IDEyLjk2ICAgfCAxMC4xMyAgIHwgOC4yNSAgICB8CgrotYTmlpnmnaXmupDvvJrliKnmsJHmuK/otKfvvIzoja/noJTlsI/mnKjlrZDvvIzljLvoja/prZTmlrnvvIzmlrnmraPor4HliLjnoJTnqbbmiYA=
收藏
其它
2024-07-10
原图定位
查看详情
图18埃克替尼发展历程及预测
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
收藏
行业数据
2023-07-17
原图定位
查看详情
表7埃克替尼辅助治疗用药患者人数估算
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
收藏
行业数据
2023-07-17
原图定位
查看详情
表9埃克替尼一线治疗患者人数估算
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
收藏
行业数据
2023-07-17
原图定位
查看详情
我国ALKTKI竞争格局
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
收藏
行业数据
2023-05-08
原图定位
查看详情
2013-2021年埃克替尼销售收入及同比变动(单位:百万元)
fOW5tOS7vXzln4PlhYvmm7/lsLzplIDllK7mlLblhaXvvIjnmb7kuIflhYPvvIl85ZCM5q+UfAp8LXwtfC18CnwyMDEz5bm0fDQ3NXwtfAp8MjAxNOW5tHw3MDN8NDguMDAlfAp8MjAxNeW5tHw5MTN8MjkuODclfAp8MjAxNuW5tHwxMDM1fDEzLjM2JXwKfDIwMTflubR8MTAyNnwtMC44NyV8CnwyMDE45bm0fDEyMDh8MTcuNzQlfAp8MjAxOeW5tHwxNTAyfDI0LjM0JXwKfDIwMjDlubR8MTgxM3wyMC43MSV8CnwyMDIx5bm0fDIwNTZ8MTMuNDAlfAoK6LWE5paZ5p2l5rqQ77ya6LSd6L6+6I2v5Lia5YWs5ZGK77yM6K+B5Yi45LmL5pif77yM5aSp6aOO6K+B5Yi456CU56m25omA
收藏
行业数据
2023-04-20
原图定位
查看详情
埃克替尼销售额(亿元)
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
收藏
行业数据
2023-03-16
原图定位
查看详情
ALKTKI数据对比
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
收藏
行业数据
2023-03-07
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
TGRX-326:引进三代 ALK抑制剂,在优势领域发挥产品长 DOT潜力。2024年 9月公司就三代 ALK抑制剂 TGRX-326与塔吉瑞订立合作协议,该产品用于治疗 ALK基因变异的 NSCLC,特别是针对第一、二代耐药的 G1202R突变展示良好效果。2024 年 11月,TGRX-326 片在 ALK 阳性非小细胞肺癌患者中的 1b 期研究结果刊登于国际知名医学领域期刊 Journal ofThoracic Oncology:2021 年 4 月至 2023 年 3 月共有 198 例患者入组,选定 60 mg,每天一次作为适应症扩展阶段给药剂量,共 156 例受试者进入适应症扩展阶段,接受过克唑替尼治疗、接受过二代 ALK 抑制剂治疗、既往均未接受过 ALK 抑制剂治疗的 ORR=71.4%、38.1%、87.9%,中位无进展时间=未达到、6.9 个月、未达到;对于颅内有可测量病灶的患者来说,三组的颅内 ORR=50%、70.4%和 75%。近期三代 ALK 抑制剂代表品种劳拉替尼针对一线 ALK+NSCLC 的 CROWN 研究 5 年随访数据发布:ORR=76% vs 58%;中位无进展生存期=未达到 vs 9.1 个月(劳拉替尼 vs克唑替尼),两者的 PFS曲线在用药后迅速显现明显分离,据此预计三代ALK抑制剂针对一线 ALK+NSCLC有望实现长无进展生存期进而具备长用药周期,TGRX-326针对未经 ALK抑制剂治疗的 ALK+NSCLC的 III期临床研究正处于招募阶段,主要终点为 PFS,公司在肺癌领域具备扎实的产品销售经验,若 TGRX-326能够成功上市则有望顺利发挥长用药周期潜力。
行业数据
原图定位
当前图表所属:
先声药业-港股公司深度报告:神经+肿瘤+自免三栖产品矩阵升级+研发创佳绩-250223(31页).pdf
先必新舌下片有望同注射剂形成产品协同
公司24H1收入结构
公司2020年以来费用率
公司2020年以来毛利率及净利率
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》